人附睾蛋白4、糖类抗原125、抑制素B及抗苗勒管激素在卵巢颗粒细胞瘤鉴别诊断与随访中的作用
研究测量135份成人型颗粒细胞瘤(AGCT)样本、37例上皮性卵巢癌(EOC)和40例子宫内膜异位囊肿(ENDO)患者的循环标志物HE4、CA125、抑制素B和AMH,比较其诊断准确性。结果显示AGCT中HE4和CA125水平低,抑制素B是区分AGCT与EOC及ENDO最准确的标志物,也是AGCT随访的最佳单一标志物。
要点
- AGCT患者HE4水平显著低于EOC患者(p<0.0001)。
- 抑制素B单独即可区分AGCT与EOC。
- 抑制素B与AMH联合区分AGCT与ENDO的灵敏度100%、特异度93%。
核心结论
- AGCT中HE4和CA125水平低,抑制素B是区分AGCT与EOC及ENDO最准确的循环生物标志物。
- 抑制素B也是AGCT随访的最佳单一标志物。
研究设计与样本
- 研究测量135份AGCT患者样本、37例EOC患者和40例ENDO患者的HE4、CA125、抑制素B和AMH水平。
- 采用受试者工作特征(ROC)曲线并计算比较不同标志物的曲线下面积(AUC)。
主要发现
- AGCT患者HE4水平显著低于EOC患者(p<0.0001)。
- CA125水平高于35IU/l者在AGCT患者中占25%,在ENDO患者中占47.5%。
- 抑制素B和AMH水平仅在AGCT患者中升高。
- AUC比较分析中,抑制素B单独即足以区分AGCT与EOC。
- 区分AGCT与ENDO时,抑制素B与AMH表现相似,两者联合较任一标志物单独提高准确性(灵敏度100%;特异度93%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Evaluation of circulating tumor markers in ovarian cancer is crucial for optimal patient care. The goal of this study was to verify the most accurate circulating tumor markers for the diagnosis and follow-up of adult-type granulosa cell tumors (AGCTs). METHODS: The levels of circulating human epididymis protein 4 (HE4) and carbohydrate antigen 125 (CA125), together with AGCT markers inhibin B and anti-Müllerian hormone (AMH), were measured in 135 samples from AGCT patients, 37 epithelial ovarian carcinoma (EOC) patients, and 40 endometrioma (ENDO) patients. The levels were plotted with receiver operating characteristic (ROC) graphs, and the area under the curves (AUC) of the different markers were calculated and compared. RESULTS: HE4 levels were significantly lower in AGCTs than in EOCs (p<0.0001). CA125 levels were above 35IU/l in 25% of AGCT patients and 47.5% of ENDO patients, whereas inhibin B and AMH levels were elevated only in patients with AGCTs. In the AUC comparison analyses, inhibin B alone was sufficient to differentiate AGCT from EOC. In differentiating AGCT from ENDO, inhibin B and AMH performed similarly, and the combination of inhibin B and AMH increased the accuracy compared to either marker alone (sensitivity, 100%; specificity, 93%). Among AGCT patients, inhibin B was the best marker for detecting the presence of AGCT. CONCLUSIONS: HE4 and CA125 levels were low in AGCTs, and inhibin B was the most accurate circulating biomarker in distinguishing AGCTs from EOCs and from ENDOs. Inhibin B was also the best single marker for AGCT follow-up.
引用
- Haltia UM, Hallamaa M, Tapper J, et al. Roles of human epididymis protein 4, carbohydrate antigen 125, inhibin B and anti-Müllerian hormone in the differential diagnosis and follow-up of ovarian granulosa cell tumors. Gynecol Oncol. 2016. PMID: 27871721. doi:10.1016/j.ygyno.2016.11.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。